TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
180 Life Sciences ( (ATNF) ) just unveiled an update.
On July 29, 2025, 180 Life Sciences Corp. announced a significant private placement agreement to raise $425 million, aiming to establish an Ethereum treasury reserve and rebrand as ETHZilla Corporation. The transaction, expected to close on August 1, 2025, involves selling common stock and pre-funded warrants to institutional investors. The proceeds will be used to purchase Ethereum and support the company’s new digital asset strategy. This strategic move positions the company to capitalize on the growing Ethereum ecosystem and aims to deliver value to shareholders by leveraging Ethereum’s potential in decentralized finance.
More about 180 Life Sciences
180 Life Sciences Corp. operates in the biotechnology sector, focusing on developing therapies for inflammatory diseases. The company is now expanding its operations to include a digital asset treasury strategy centered around Ethereum, aiming to leverage staking, lending, and liquidity provisioning.
Average Trading Volume: 2,199,710
Technical Sentiment Signal: Buy
Current Market Cap: $17.57M
Learn more about ATNF stock on TipRanks’ Stock Analysis page.